S Winer, MD, MPH

Professor of Clinical Obstetrics & Gynecology, Co-Director, REI Clinic

Image of S Winer, MD, MPH
Is this your profile? Click to edit

Publications

  • Prevalence of endometrial hyperplasia and carcinoma in women with polycystic ovarian syndrome. F S Rep. 2025 Sep; 6(3):394-398.. View in PubMed
  • Comparison of estrogens and selective estrogen receptor modulators (SERMs) used for menopausal hormone therapy. Menopause. 2025 Aug 01; 32(8):730-757.. View in PubMed
  • Letters to the Editor. Menopause. 2025 Jul 01; 32(7):669-671.. View in PubMed
  • A comparison of letrozole regimens for ovulation induction in women with polycystic ovary syndrome. F S Rep. 2024 Jun; 5(2):170-175.. View in PubMed
  • Comparison of estrogenic components used for hormonal contraception. Contraception. 2024 02; 130:110310.. View in PubMed
  • Family Planning, Fertility, and Medical School: A Survey of Students’ Plans and Perceptions of Institutional Support. Perm J. 2023 09 15; 27(3):37-48.. View in PubMed
  • Does timing matter when initiating elagolix in a natural menstrual cycle? F S Rep. 2021 Sep; 2(3):308-313.. View in PubMed
  • Bioidentical hormones. Climacteric. 2021 02; 24(1):38-45.. View in PubMed
  • Successful Vaginal Delivery after External Cephalic Version in a Woman with a Large Partial Uterine Septum. Case Rep Obstet Gynecol. 2021; 2021:9912271.. View in PubMed
  • Effect of hormone therapy on breast epithelial cell proliferation. Menopause. 2013 May; 20(5):483-5.. View in PubMed
  • Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev. 2013 Apr; 34(2):171-208.. View in PubMed
  • Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness. Expert Rev Pharmacoecon Outcomes Res. 2009 Apr; 9(2):157-70.. View in PubMed
  • The pharmacologic management of premenstrual dysphoric disorder. Expert Opin Pharmacother. 2008 Feb; 9(3):429-45.. View in PubMed
  • Drospirenone/ethinyl estradiol. Drugs Today (Barc). 2008 Feb; 44(2):133-45.. View in PubMed
  • Ethinyl estradiol/drospirenone for the treatment of the emotional and physical symptoms of premenstrual dysphoric disorder. Womens Health (Lond). 2007 Jul; 3(4):395-408.. View in PubMed
  • Drospirenone: a novel progestin. Expert Opin Pharmacother. 2007 May; 8(7):989-99.. View in PubMed
  • Premenstrual disorders: prevalence, etiology and impact. J Reprod Med. 2006 Apr; 51(4 Suppl):339-47.. View in PubMed